February 14, 2026CJC OpenOpen Access

Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy

View Full Paper

Ask AI

Bookmark

Why the study?

Large cohort studies of pregnant women with HCM are limited, and management practices vary across centres without protocolized care.

Design

Review

Authors

AMAdhya MehtaInova Health System SSSarah SchumacherUniversity of Potsdam RBRebekah Alison BhansaliJohns Hopkins University

Discussion

Member takes

Implication

Management of pregnant women with HCM varies without standardized protocols; leaves open the need for prospective studies to inform care.

Structured PICO

Population

Pregnant women with hypertrophic cardiomyopathy (HCM)

Intervention

Management strategies including medical therapy and invasive procedures (alcohol septal ablation, cardiac myomectomy)

This review underscores the unique cardiovascular challenges of managing hypertrophic cardiomyopathy during pregnancy and calls for standardized care protocols to optimize maternal and fetal outcomes.

Limitations

Large cohort studies of women with HCM are very limited
Management practices vary within centres, with no protocolized care

Cite This Study

Mehta et al. (2026) studied this question.

synapsesocial.com/papers/6a7d1ad0342883c6199fff46 https://doi.org/10.1016/j.cjco.2026.02.007

View Full Paper

Ask AI

Bookmark

Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider